Trophogen Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

Trophogen General Information

Description

Operator of a biotechnology platform designed to focus on the development of growth factors for therapeutic applications. The company's platform offers high-affinity glycoprotein hormones, veterinary reproduction agents, and related growth factor analogs for enhanced reproductive outcomes, enabling fertility specialists, cancer researchers, and medical professionals to treat ovarian, breast, prostate, testicular, and thyroid cancers as well as human and animal infertility.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 9430 Key West Avenue
  • Suite 155
  • Rockville, MD 20850
  • United States
+1 (301)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 9430 Key West Avenue
  • Suite 155
  • Rockville, MD 20850
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trophogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Secondary Transaction - Private 01-Dec-2020 Completed Clinical Trials - Phase 2
15. Grant 01-Aug-2018 Completed Clinical Trials - Phase 2
14. Grant 18-Sep-2017 Completed Clinical Trials - Phase 2
13. Grant 22-Aug-2017 Completed Clinical Trials - Phase 2
12. Later Stage VC (Series B) 14-Feb-2017 Cancelled Clinical Trials - Phase 2
11. Grant 08-Jul-2015 Completed Clinical Trials - Phase 2
10. Grant 21-Apr-2014 Completed Clinical Trials - Phase 2
9. Grant 11-Sep-2012 Completed Clinical Trials - Phase 2
8. Grant 12-Sep-2011 $1.94M $3.5M Completed Clinical Trials - Phase 2
7. Grant 29-Oct-2010 $478K $3.5M Completed Clinical Trials - Phase 2
To view Trophogen’s complete valuation and funding history, request access »

Trophogen Patents

Trophogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024233992-A2 Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs Inactive 11-May-2023
WO-2024233992-A3 Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs Inactive 11-May-2023
AU-2014346859-A1 Glycoprotein hormone long-acting superagonists Active 05-Nov-2013
AU-2014346859-B2 Glycoprotein hormone long-acting superagonists Inactive 05-Nov-2013
CA-2929561-A1 Glycoprotein hormone long-acting superagonists Pending 05-Nov-2013 C07K14/59
To view Trophogen’s complete patent history, request access »

Trophogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trophogen FAQs

  • When was Trophogen founded?

    Trophogen was founded in 2001.

  • Where is Trophogen headquartered?

    Trophogen is headquartered in Rockville, MD.

  • What is the size of Trophogen?

    Trophogen has 10 total employees.

  • What industry is Trophogen in?

    Trophogen’s primary industry is Biotechnology.

  • Is Trophogen a private or public company?

    Trophogen is a Private company.

  • What is Trophogen’s current revenue?

    The current revenue for Trophogen is .

  • How much funding has Trophogen raised over time?

    Trophogen has raised $3.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process